Skip to main content

Rsv vaccine, pref a-pref b, recombinant Disease Interactions

There are 2 disease interactions with rsv vaccine, pref a-pref b, recombinant.

Moderate

RSV vaccine (applies to rsv vaccine, pref a-pref b, recombinant) immunodeficiency

Moderate Potential Hazard, Moderate plausibility.

Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a diminished immune response to the RSV vaccine.

References (3)
  1. (2024) "Product Information. Mresvia Prefilled Syringe (cvx 326) (RSV mRNA vaccine (cvx 326))." Moderna US, Inc
  2. (2024) "Product Information. Arexvy (RSV vaccine preF3, recombinant)." GlaxoSmithKline
  3. (2025) "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group, STN 125769/388
Moderate

RSV vaccine (applies to rsv vaccine, pref a-pref b, recombinant) syncope

Moderate Potential Hazard, Moderate plausibility.

Syncope may occur in association with administration of injectable vaccines, including the RSV vaccine. Procedures should be in place to avoid injury from fainting, especially for patients who have previously fainted in association with an injection.

References (3)
  1. (2024) "Product Information. Mresvia Prefilled Syringe (cvx 326) (RSV mRNA vaccine (cvx 326))." Moderna US, Inc
  2. (2024) "Product Information. Arexvy (RSV vaccine preF3, recombinant)." GlaxoSmithKline
  3. (2025) "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group, STN 125769/388

Switch to consumer interaction data

Rsv vaccine, pref a-pref b, recombinant drug interactions

There are 299 drug interactions with rsv vaccine, pref a-pref b, recombinant.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer